Results 141 to 150 of about 22,676 (187)

Epigenetics of cancer : a new way to manage oncology patients [PDF]

, 2014
Martínez-Escardó, L., Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

Life-Threatening Thrombotic Events Revealing Systemic Lupus Erythematosus in a Patient with Chronic Myelomonocytic Leukaemia. [PDF]

Eur J Case Rep Intern Med
Khadidja A, Salle V, Joris M, Schmidt J, Marolleau JP.   +4 more
europepmc   +1 more source

Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia. [PDF]

Ann Hematol
Ji Q, Jiang X, Li X, Cao C, Zhang X, Zhou M, Ma S, Chen C.   +7 more
europepmc   +1 more source

ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed <i>IDH1</i> mutant acute myeloid leukemia. [PDF]

Future Oncol
Vyas P, Salek S, Vives S, Recher C, Döhner H, Venditti A, Derrien H, Chatin S, De La Bigne AM, Pelouchova J, Hills R, Nier S.   +11 more
europepmc   +1 more source

Treatment of Acute Myeloid Leukemia in Elderly Patients With Azacitidine-Venetoclax Combination in Developing Countries: A Single-Center Experience. [PDF]

Cureus
Chakara R, Mohamed Amine A, Raissi A.
europepmc   +1 more source

Toward therapeutic development for ML-DS. [PDF]

Blood Adv
Tomizawa D.
europepmc   +1 more source

Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives. [PDF]

Oncol Res
Chen T, Kim G, Rahimi Y, Kamdar M, Fernandez-Hernandez E, Woan K, Tam EL, Yaghmour G.   +7 more
europepmc   +1 more source

Quantitative Stability Evaluation of Reconstituted Azacitidine Under Clinical Storage Conditions. [PDF]

Pharmaceuticals (Basel)
Ruga S, Lombardi R, Bocci T, Armenise M, Masullo M, Lamesta C, Bava R, Castagna F, Matarese E, Di Viesti MP, Biancofiore A, Liguori G, Palma E.   +12 more
europepmc   +1 more source

The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia. [PDF]

Blood Res
Prajapati S, Jyotishi C, Patel M, Gupta R.   +3 more
europepmc   +1 more source

Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML. [PDF]

Blood Adv
Montesinos P, Marchione DM, Recher C, Heuser M, Vives S, Zarzycka E, Wang J, Riva M, Calado RT, Schuh AC, Yeh SP, Tron AE, Hui J, Gianolio DA, Choe S, Patel P, De Botton S, DiNardo CD, Döhner H.   +18 more
europepmc   +1 more source